arrow
Y

Yaroslav Tsybovsky

frederick national laboratory for cancer research
H指数:45
被引数:8,197

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21

纳米颗粒CIS43基连接区疫苗单独或与R21联合使用对疟疾的保护性免疫

2026-04-270
OAAI
Demonstration of in vivo efficacy, cryo-EM-epitope identification, and breadth of two anti-alphavirus bispecific single domain antibodies

体内功效的展示、cryo-EM表位识别以及两种抗alphavirus双特异性单域抗体的广谱性

2025-12-010
PRE
Cross-neutralizing and potent human monoclonal antibodies against historical and emerging H5Nx influenza viruses

针对历史和新兴H5Nx流感病毒的交叉中和强效人单克隆抗体

2025-10-140
OAAI
Functional; immunogenetic; and structural convergence in influenza immunity between humans and macaques

功能、免疫遗传和结构趋同在人类和恒河猴流感免疫中的表现

2025-09-100
OA
HKU5 bat merbecoviruses engage bat and mink ACE2 as entry receptors

HKU5蝙蝠mers冠状病毒利用蝙蝠和貂ACE2作为进入受体

2025-07-240
OAAI
Inclusion of a retroviral protease enhances the immunogenicity of VLP-forming mRNA vaccines against HIV-1 or SARS-CoV-2 in mice

将逆转录病毒蛋白酶包含在内可增强小鼠中针对HIV-1或SARS-CoV-2的VLP形成mRNA疫苗的免疫原性

2025-04-300
PRE
A broadly protective human antibody for GI genogroup noroviruses

一种广谱保护性人源抗体,针对GI基因群诺如病毒

2025-04-100
PRE
Broadly neutralizing antibodies targeting pandemic GII.4 variants or seven GII genotypes of human norovirus

广谱中和抗体靶向大流行性GII.4变种或人诺如病毒的七种GII基因型

2025-03-050
PRE
Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350

通过Epstein-Barr病毒gp350介导补体受体结合及病毒中和的结构基础

IMMUNITY
IF26.3
2025-02-011
OAAI
MERS-CoV spike vaccine-induced N-terminal domain specific antibodies are more protective than receptor binding domain-specific antibodies-

MERS-CoV刺突疫苗诱导的N端结构域特异性抗体比受体结合结构域特异性抗体具有更强的保护作用。

2025-02-010
OAAI
Early influenza virus exposure shapes the B cell response to influenza vaccination in individuals 50 years later

早期流感病毒暴露塑造了50年后个体对流感疫苗接种的B细胞反应

IMMUNITY
IF26.3
2025-02-010
PRE
Modulating the immunodominance hierarchy of immunoglobulin germline-encoded structural motifs targeting the influenza hemagglutinin stem
2024-12-010
OAAI
Structure- based design of glycoprotein subunit vaccines for mumps

基于结构的腮腺炎糖蛋白亚单位疫苗的设计

2024-11-110
OAAI
Ultrapotent Broadly Neutralizing Human-llama Bispecific Antibodies against HIV-1

超广谱广谱中和人-美洲驼双特异性HIV-1抗体

2024-05-050
OAAI
Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase
IMMUNITY
IF26.3
2024-03-014
OA
Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability
2024-01-044
OAAI
Extraordinary Titer and Broad Anti-SARS-CoV-2 Neutralization Induced by Stabilized RBD Nanoparticles from Strain BA.5
2023-12-284
OAAI